These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005. van Loon RL; Roofthooft MT; Hillege HL; ten Harkel AD; van Osch-Gevers M; Delhaas T; Kapusta L; Strengers JL; Rammeloo L; Clur SA; Mulder BJ; Berger RM Circulation; 2011 Oct; 124(16):1755-64. PubMed ID: 21947294 [TBL] [Abstract][Full Text] [Related]
11. Bosentan for pulmonary hypertension and other pulmonary diseases: emerging evidence. Frantz RP Future Cardiol; 2008 Sep; 4(5):459-68. PubMed ID: 19804340 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. Zlupko M; Harhay MO; Gallop R; Shin J; Archer-Chicko C; Patel R; Palevsky HI; Taichman DB Respir Med; 2008 Oct; 102(10):1431-8. PubMed ID: 18617379 [TBL] [Abstract][Full Text] [Related]
13. [Pulmonary arterial hypertension in children: new therapeutic approaches]. Beghetti M Ann Fr Anesth Reanim; 2007 Jun; 26(6):570-5. PubMed ID: 17524605 [TBL] [Abstract][Full Text] [Related]
14. Biological serum markers in the management of pediatric pulmonary arterial hypertension. Van Albada ME; Loot FG; Fokkema R; Roofthooft MT; Berger RM Pediatr Res; 2008 Mar; 63(3):321-7. PubMed ID: 18287971 [TBL] [Abstract][Full Text] [Related]
15. [Seven years of experience in patients with pulmonary arterial hypertension in Ege University Hospital: diagnostic approach of a single center]. Kayikçioğlu M; Kültürsay H Anadolu Kardiyol Derg; 2008 Aug; 8(4):279-85. PubMed ID: 18676304 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment. Distler O; Pignone A Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv22-5. PubMed ID: 16980719 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension. Melnick L; Barst RJ; Rowan CA; Kerstein D; Rosenzweig EB Am J Cardiol; 2010 May; 105(10):1485-9. PubMed ID: 20451700 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary arterial hypertension in the pediatric age. Donti A; Formigari R; Ragni L; Manes A; Galiè N; Picchio FM J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):72-7. PubMed ID: 17255821 [TBL] [Abstract][Full Text] [Related]
19. Intraoperative management of pulmonary arterial hypertension in infants and children--corrected and republished article. Galante D Curr Opin Anaesthesiol; 2011 Aug; 24(4):468-71. PubMed ID: 21659866 [TBL] [Abstract][Full Text] [Related]
20. [Pulmonary arterial hypertension: past, present and future]. Aytekin M; Caylak E Tuberk Toraks; 2010; 58(1):100-7. PubMed ID: 20517738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]